{"id":1027,"date":"2018-01-16T13:18:55","date_gmt":"2018-01-16T12:18:55","guid":{"rendered":"https:\/\/www.joffeassocies.com\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/"},"modified":"2018-01-16T13:18:55","modified_gmt":"2018-01-16T12:18:55","slug":"pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me","status":"publish","type":"post","link":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/","title":{"rendered":"Pherecydes Pharma boucle un 2\u00e8me tour de table \u00e0 8,7 M\u20ac"},"content":{"rendered":"<p>N\u00e9e en 2007 avec l\u2019objectif de d\u00e9velopper de nouvelles solutions contre les infections bact\u00e9riennes multi-r\u00e9sistantes, Pherecydes Pharma s\u2019est rapidement sp\u00e9cialis\u00e9e dans la conception de cocktails de virus bact\u00e9riophages lytiques. Ses travaux b\u00e9n\u00e9ficiant depuis peu d\u2019une ATU (autorisation temporaire d\u2019utilisation) pour des traitements compassionnels, la biotech vient de boucler un deuxi\u00e8me tour de table de 8,7 M\u20ac pour en lancer la production et poursuivre ses recherches annexes.<\/p>\n<p>Un montant qu\u2019elle a r\u00e9colt\u00e9 aupr\u00e8s de plusieurs nouveaux entrants (Go Capital, Omnes Capital, Fa Di\u00e8se et plusieurs business angels de la r\u00e9gion Rh\u00f4ne-Alpes) et de ses actionnaires historiques ACE Management, Auriga Partners et Participations Besan\u00e7on. Ces derniers avaient d\u00e9j\u00e0 inject\u00e9 2,6 M\u20ac dans la biotech, en mars 2015. Ce renforcement des fonds propres devra \u00e9galement financer le lancement des \u00e9tudes cliniques de deux autres programmes : Phosa, dans le traitement du staphylocoque dor\u00e9, d\u00e8s fin 2018, et Pneumophage, dans celui du bacille pyocyanique, quelques mois plus tard.<\/p>\n<p>Conseil juridique cible : Joffe &amp; Associes (Christophe Joffe, Charlotte Viandaz)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>N\u00e9e en 2007 avec l\u2019objectif de d\u00e9velopper de nouvelles solutions contre les infections bact\u00e9riennes multi-r\u00e9sistantes, Pherecydes Pharma s\u2019est rapidement sp\u00e9cialis\u00e9e dans la conception de cocktails de virus bact\u00e9riophages lytiques. Ses travaux b\u00e9n\u00e9ficiant depuis peu d\u2019une ATU (autorisation temporaire d\u2019utilisation) pour des traitements compassionnels, la biotech vient de boucler un deuxi\u00e8me tour de table de 8,7 [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":228,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1027","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-deals"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.4 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Pherecydes Pharma boucle un tour de table \u00e0 8,7 M\u20ac - Joffe &amp; Associ\u00e9s<\/title>\n<meta name=\"description\" content=\"N\u00e9e en 2007 avec l\u2019objectif de d\u00e9velopper de nouvelles solutions contre les infections bact\u00e9riennes multi-r\u00e9sistantes, Pherecydes Pharma s\u2019est rapidement sp\u00e9cialis\u00e9e dans la conception de cocktails de virus bact\u00e9riophages lytiques.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pherecydes Pharma boucle un 2\u00e8me tour de table \u00e0 8,7 M\u20ac\" \/>\n<meta property=\"og:description\" content=\"N\u00e9e en 2007 avec l\u2019objectif de d\u00e9velopper de nouvelles solutions contre les infections bact\u00e9riennes multi-r\u00e9sistantes, Pherecydes Pharma s\u2019est rapidement sp\u00e9cialis\u00e9e dans la conception de cocktails de virus bact\u00e9riophages lytiques.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/\" \/>\n<meta property=\"og:site_name\" content=\"Joffe &amp; Associ\u00e9s\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-16T12:18:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1186\" \/>\n\t<meta property=\"og:image:height\" content=\"711\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Blaise Deltombe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@JoffeAssocies\" \/>\n<meta name=\"twitter:site\" content=\"@JoffeAssocies\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Blaise Deltombe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/\"},\"author\":{\"name\":\"Blaise Deltombe\",\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/1e4e86e4066938387ee59b3004797f29\"},\"headline\":\"Pherecydes Pharma boucle un 2\u00e8me tour de table \u00e0 8,7 M\u20ac\",\"datePublished\":\"2018-01-16T12:18:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/\"},\"wordCount\":190,\"image\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png\",\"articleSection\":[\"Deals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/\",\"url\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/\",\"name\":\"Pherecydes Pharma boucle un tour de table \u00e0 8,7 M\u20ac - Joffe & Associ\u00e9s\",\"isPartOf\":{\"@id\":\"https:\/\/www.joffeassocies.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png\",\"datePublished\":\"2018-01-16T12:18:55+00:00\",\"author\":{\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/1e4e86e4066938387ee59b3004797f29\"},\"description\":\"N\u00e9e en 2007 avec l\u2019objectif de d\u00e9velopper de nouvelles solutions contre les infections bact\u00e9riennes multi-r\u00e9sistantes, Pherecydes Pharma s\u2019est rapidement sp\u00e9cialis\u00e9e dans la conception de cocktails de virus bact\u00e9riophages lytiques.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#primaryimage\",\"url\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png\",\"contentUrl\":\"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png\",\"width\":1186,\"height\":711},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.joffeassocies.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pherecydes Pharma boucle un 2\u00e8me tour de table \u00e0 8,7 M\u20ac\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.joffeassocies.com\/#website\",\"url\":\"https:\/\/www.joffeassocies.com\/\",\"name\":\"Joffe &amp; Associ\u00e9s\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.joffeassocies.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/1e4e86e4066938387ee59b3004797f29\",\"name\":\"Blaise Deltombe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.joffeassocies.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/16ce097f0278128cf4f11d1d73a8654c41788c9edd8626caa408070bf1d66845?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/16ce097f0278128cf4f11d1d73a8654c41788c9edd8626caa408070bf1d66845?s=96&d=mm&r=g\",\"caption\":\"Blaise Deltombe\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pherecydes Pharma boucle un tour de table \u00e0 8,7 M\u20ac - Joffe & Associ\u00e9s","description":"N\u00e9e en 2007 avec l\u2019objectif de d\u00e9velopper de nouvelles solutions contre les infections bact\u00e9riennes multi-r\u00e9sistantes, Pherecydes Pharma s\u2019est rapidement sp\u00e9cialis\u00e9e dans la conception de cocktails de virus bact\u00e9riophages lytiques.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/","og_locale":"en_US","og_type":"article","og_title":"Pherecydes Pharma boucle un 2\u00e8me tour de table \u00e0 8,7 M\u20ac","og_description":"N\u00e9e en 2007 avec l\u2019objectif de d\u00e9velopper de nouvelles solutions contre les infections bact\u00e9riennes multi-r\u00e9sistantes, Pherecydes Pharma s\u2019est rapidement sp\u00e9cialis\u00e9e dans la conception de cocktails de virus bact\u00e9riophages lytiques.","og_url":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/","og_site_name":"Joffe &amp; Associ\u00e9s","article_published_time":"2018-01-16T12:18:55+00:00","og_image":[{"width":1186,"height":711,"url":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png","type":"image\/png"}],"author":"Blaise Deltombe","twitter_card":"summary_large_image","twitter_creator":"@JoffeAssocies","twitter_site":"@JoffeAssocies","twitter_misc":{"Written by":"Blaise Deltombe","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#article","isPartOf":{"@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/"},"author":{"name":"Blaise Deltombe","@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/1e4e86e4066938387ee59b3004797f29"},"headline":"Pherecydes Pharma boucle un 2\u00e8me tour de table \u00e0 8,7 M\u20ac","datePublished":"2018-01-16T12:18:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/"},"wordCount":190,"image":{"@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#primaryimage"},"thumbnailUrl":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png","articleSection":["Deals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/","url":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/","name":"Pherecydes Pharma boucle un tour de table \u00e0 8,7 M\u20ac - Joffe & Associ\u00e9s","isPartOf":{"@id":"https:\/\/www.joffeassocies.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#primaryimage"},"image":{"@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#primaryimage"},"thumbnailUrl":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png","datePublished":"2018-01-16T12:18:55+00:00","author":{"@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/1e4e86e4066938387ee59b3004797f29"},"description":"N\u00e9e en 2007 avec l\u2019objectif de d\u00e9velopper de nouvelles solutions contre les infections bact\u00e9riennes multi-r\u00e9sistantes, Pherecydes Pharma s\u2019est rapidement sp\u00e9cialis\u00e9e dans la conception de cocktails de virus bact\u00e9riophages lytiques.","breadcrumb":{"@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#primaryimage","url":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png","contentUrl":"https:\/\/www.joffeassocies.com\/wp-content\/uploads\/2018\/01\/img-mag.png","width":1186,"height":711},{"@type":"BreadcrumbList","@id":"https:\/\/www.joffeassocies.com\/en\/pherecydes-pharma-boucle-2eme-tour-de-table-a-87-me\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.joffeassocies.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pherecydes Pharma boucle un 2\u00e8me tour de table \u00e0 8,7 M\u20ac"}]},{"@type":"WebSite","@id":"https:\/\/www.joffeassocies.com\/#website","url":"https:\/\/www.joffeassocies.com\/","name":"Joffe &amp; Associ\u00e9s","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.joffeassocies.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/1e4e86e4066938387ee59b3004797f29","name":"Blaise Deltombe","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.joffeassocies.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/16ce097f0278128cf4f11d1d73a8654c41788c9edd8626caa408070bf1d66845?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/16ce097f0278128cf4f11d1d73a8654c41788c9edd8626caa408070bf1d66845?s=96&d=mm&r=g","caption":"Blaise Deltombe"}}]}},"_links":{"self":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts\/1027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/comments?post=1027"}],"version-history":[{"count":0,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/posts\/1027\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/media\/228"}],"wp:attachment":[{"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/media?parent=1027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/categories?post=1027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.joffeassocies.com\/en\/wp-json\/wp\/v2\/tags?post=1027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}